FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Richard Winneker

Research Profile

Chemicals & Drugs

Living Beings

Concepts & Ideas

Physiology

Binding, Competitive

Procedures

Ovariectomy

Anatomy

Genes & Molecular Sequences

Molecular Structure

Co-author Network

Publications

TOP 3
Casey McComas; Edward Melenski; Cheryl Mugford; Ov Slayden; Richard Winneker; Jay Wrobel; Matthew R Yudt; Jeffrey Cohen; Christine Huselton; Michael Marella; Andrew Fensome
Novel progesterone receptor modulators: 4-aryl-phenylsulfonamides.
Matthew R Yudt; Zhiming Zhang; Jay Wrobel; Thomas J Berrodin; Jeff C Cohen; Neil Cooch; Debra Ellis; Andrew Fensome; Elizabeth Haglund; Scott A Jelinsky; Sunil Nagpal; Louise A Russo; Raymond J Unwalla; Richard Winneker
Discovery of a novel mechanism of steroid receptor antagonism: WAY-255348 modulates progesterone receptor cellular localization and promoter interactions.
Adrienne S McCampbell; Heather A Harris; Judy S Crabtree; Richard Winneker; Cheryl L Walker; Russell R Broaddus
Loss of inhibitory insulin receptor substrate-1 phosphorylation is an early event in mammalian target of rapamycin-dependent endometrial hyperplasia and carcinoma.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Richard Winneker (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Casey McComas; Edward Melenski; Cheryl Mugford; Ov Slayden; Richard Winneker; Jay Wrobel; Matthew R Yudt; Jeffrey Cohen; Christine Huselton; Michael Marella; Andrew Fensome
Novel progesterone receptor modulators: 4-aryl-phenylsulfonamides.
Bioorganic & medicinal chemistry letters 2012;22(23):7119-22.
2011: Matthew R Yudt; Zhiming Zhang; Jay Wrobel; Thomas J Berrodin; Jeff C Cohen; Neil Cooch; Debra Ellis; Andrew Fensome; Elizabeth Haglund; Scott A Jelinsky; Sunil Nagpal; Louise A Russo; Raymond J Unwalla; Richard Winneker
Discovery of a novel mechanism of steroid receptor antagonism: WAY-255348 modulates progesterone receptor cellular localization and promoter interactions.
Biochemical pharmacology 2011;82(11):1709-19.
2010: Adrienne S McCampbell; Heather A Harris; Judy S Crabtree; Richard Winneker; Cheryl L Walker; Russell R Broaddus
Loss of inhibitory insulin receptor substrate-1 phosphorylation is an early event in mammalian target of rapamycin-dependent endometrial hyperplasia and carcinoma.
Cancer prevention research (Philadelphia, Pa.) 2010;3(3):290-300.
2009: Jeffrey C Kern; Eugene A Terefenko; Eugene Trybulski; Thomas J Berrodin; Jeffrey Cohen; Richard Winneker; Matthew R Yudt; Zhiming Zhang; Yuan Zhu; Puwen Zhang
5-Aryl indanones and derivatives as non-steroidal progesterone receptor modulators.
Bioorganic & medicinal chemistry letters 2009;19(23):6666-9.
2009: Gavin D Heffernan; Richard D Coghlan; Eric S Manas; Robert E McDevitt; Yanfang Li; Paige E Mahaney; Albert J Robichaud; Christine Huselton; Peter Alfinito; Jenifer A Bray; Scott A Cosmi; Grace H Johnston; Thomas Kenney; Elizabeth Koury; Richard Winneker; Darlene C Deecher; Eugene J Trybulski
Dual acting norepinephrine reuptake inhibitors and 5-HT(2A) receptor antagonists: Identification, synthesis and activity of novel 4-aminoethyl-3-(phenylsulfonyl)-1H-indoles.
Bioorganic & medicinal chemistry 2009;17(22):7802-15.
2009: Judy S Crabtree; Scott A Jelinsky; Heather A Harris; Sung E Choe; Monette M Cotreau; Michelle L Kimberland; Ewa Wilson; Kathryn A Saraf; Wei Liu; Adrienne S McCampbell; Bhuvanesh Dave; Russell R Broaddus; Eugene L Brown; Wenling Kao; Jerauld S Skotnicki; Magid Abou-Gharbia; Richard Winneker; Cheryl L Walker
Comparison of human and rat uterine leiomyomata: identification of a dysregulated mammalian target of rapamycin pathway.
Cancer research 2009;69(15):6171-8.
2009: Bryan J Peano; Judy S Crabtree; Barry S Komm; Richard Winneker; Heather A Harris
Effects of various selective estrogen receptor modulators with or without conjugated estrogens on mouse mammary gland.
Endocrinology 2009;150(4):1897-903.
2009: Thomas J Berrodin; Scott A Jelinsky; Nilsa Graciani; John A Butera; Zhiming Zhang; Sunil Nagpal; Richard Winneker; Matthew R Yudt
Novel progesterone receptor modulators with gene selective and context-dependent partial agonism.
Biochemical pharmacology 2009;77(2):204-15.
2008: Heather A Harris; Vargheese M Chennathukuzhi; Xiaochun Zhang; Belew Mekonnen; Scott A Jelinsky; Scott H Schelling; Vikram S Patel; Christine Huselton; Andre Negahban; Farooq Azam; Richard Winneker
Development of an early biomarker for the ovarian liability of selective estrogen receptor modulators in rats.
The Journal of steroid biochemistry and molecular biology 2008;112(1-3):40-6.
2008: Jeffrey C Kern; Eugene A Terefenko; Andrew Fensome; Rayomand J Unwalla; Jay Wrobel; Jeffrey Cohen; Yuan Zhu; Thomas J Berrodin; Matthew R Yudt; Richard Winneker; Zhiming Zhang; Puwen Zhang
1,5-Dihydro-benzo[e][1,4]oxazepin-2(1H)-ones containing a 7-(5'-cyanopyrrol-2-yl) group as nonsteroidal progesterone receptor modulators.
Bioorganic & medicinal chemistry letters 2008;18(18):5015-7.
2008: Richard Winneker; Andrew Fensome; Puwen Zhang; Matthew R Yudt; Casey C McComas; Rayomond J Unwalla
A new generation of progesterone receptor modulators.
Steroids 2008;73(7):689-701.
2008: Puwen Zhang; Jeffrey C Kern; Eugene A Terefenko; Andrew Fensome; Rayomand J Unwalla; Zhiming Zhang; Jeffrey Cohen; Thomas J Berrodin; Matthew R Yudt; Richard Winneker; Jay Wrobel
7-aryl 1,5-dihydro-benzo[e][1,4]oxazepin-2-ones and analogs as non-steroidal progesterone receptor antagonists.
Bioorganic & medicinal chemistry 2008;16(13):6589-600.
2008: Judy S Crabtree; Bryan J Peano; Xiaochun Zhang; Barry S Komm; Richard Winneker; Heather A Harris
Activity of three selective estrogen receptor modulators on hormone-dependent responses in the mouse uterus and mammary gland.
Molecular and cellular endocrinology 2008;287(1-2):40-6.
2008: Brian J Arey; Stephen D Yanofsky; M Claudia Pérez; Christopher P Holmes; Jay Wrobel; Ariamala Gopalsamy; Panayiotis E Stevis; Francisco J López; Richard Winneker
Differing pharmacological activities of thiazolidinone analogs at the FSH receptor.
Biochemical and biophysical research communications 2008;368(3):723-8.
2008: Andrew Fensome; William R Adams; Andrea L Adams; Tom J Berrodin; Jeff Cohen; Christine Huselton; Arthur Illenberger; Jeffrey C Kern; Valerie A Hudak; Michael A Marella; Edward G Melenski; Casey C McComas; Cheryl A Mugford; Ov D Slayden; Matthew Yudt; Zhiming Zhang; Puwen Zhang; Yuan Zhu; Richard Winneker; Jay Wrobel
Design, synthesis, and SAR of new pyrrole-oxindole progesterone receptor modulators leading to 5-(7-fluoro-3,3-dimethyl-2-oxo-2,3-dihydro-1H-indol-5-yl)-1-methyl-1H-pyrrole-2-carbonitrile (WAY-255348).
Journal of medicinal chemistry 2008;51(6):1861-73.
2008: Scott A Jelinsky; Sung E Choe; Judy S Crabtree; Monette M Cotreau; Ewa Wilson; Kathryn Saraf; Andrew J Dorner; Eugene L Brown; Bryan J Peano; Xiaochun Zhang; Richard Winneker; Heather A Harris
Molecular analysis of the vaginal response to estrogens in the ovariectomized rat and postmenopausal woman.
BMC medical genomics 2008;1():27.
2007: Monette M Cotreau; Vargheese Chennathukuzhi; Heather A Harris; Lixin Han; Andrew J Dorner; Glen Apseloff; Usha Varadarajan; Ellyn Hatstat; Marjorie Zakaria; Andrew Strahs; Judy S Crabtree; Richard Winneker; Scott Jelinsky
A study of 17beta-estradiol-regulated genes in the vagina of postmenopausal women with vaginal atrophy.
Maturitas 2007;58(4):366-76.
2007: John N Mason; Darlene C Deecher; Rhonda L Richmond; Gary Stack; Paige E Mahaney; Eugene Trybulski; Richard Winneker; Randy D Blakely
Desvenlafaxine succinate identifies novel antagonist binding determinants in the human norepinephrine transporter.
The Journal of pharmacology and experimental therapeutics 2007;323(2):720-9.
2007: Puwen Zhang; Eugene A Terefenko; Jeffrey Kern; Andrew Fensome; Eugene Trybulski; Rayomand J Unwalla; Jay Wrobel; Susan Lockhead; Yuan Zhu; Jeffrey Cohen; Margaret Lacava; Richard Winneker; Zhiming Zhang
5-(3-Cyclopentyl-2-thioxo-2,3-dihydro-1H-benzimidazol-5-yl)-1-methyl-1H-pyrrole-2-carbonitrile: A novel, highly potent, selective, and orally active non-steroidal progesterone receptor agonist.
Bioorganic & medicinal chemistry 2007;15(20):6556-64.
2007: Darlene C Deecher; Peter D Alfinito; Liza Leventhal; Scott Cosmi; Grace H Johnston; Istvan Merchenthaler; Richard Winneker
Alleviation of thermoregulatory dysfunction with the new serotonin and norepinephrine reuptake inhibitor desvenlafaxine succinate in ovariectomized rodent models.
Endocrinology 2007;148(3):1376-83.
2007: Zhiming Zhang; S G Lundeen; Ov D Slayden; Yuan Zhu; Jeffrey Cohen; T J Berrodin; J Bretz; S Chippari; Jay Wrobel; Puwen Zhang; Andrew Fensome; Richard Winneker; Matthew R Yudt
In vitro and in vivo characterization of a novel nonsteroidal, species-specific progesterone receptor modulator, PRA-910.
Ernst Schering Foundation symposium proceedings 2007;(1):171-97.
2007: Jeffrey C Kern; Eugene A Terefenko; Andrew Fensome; Ray Unwallla; Jay Wrobel; Yuan Zhu; Jeffrey Cohen; Richard Winneker; Zhiming Zhang; Puwen Zhang
SAR studies of 6-(arylamino)-4,4-disubstituted-1-methyl-1,4-dihydro-benzo[d][1,3]oxazin-2-ones as progesterone receptor antagonists.
Bioorganic & medicinal chemistry letters 2007;17(1):189-92.
2006: Judy S Crabtree; Xiaochun Zhang; Bryan J Peano; Zhiming Zhang; Richard Winneker; Heather A Harris
Development of a mouse model of mammary gland versus uterus tissue selectivity using estrogen- and progesterone-regulated gene markers.
The Journal of steroid biochemistry and molecular biology 2006;101(1):11-21.
2006: Douglas C Harnish; Xiaorong Liu; Thomas Kenney; Richard Winneker; Christopher C Chadwick; Gregory S Friedrichs; Edward J Kilbourne
The pathway-selective estrogen receptor ligand WAY-169916 displays differential activity in ischemia-reperfusion injury models.
Journal of cardiovascular pharmacology 2006;47(6):788-95.
2006: Stephen D Yanofsky; Emily S Shen; Frank Holden; Erik Whitehorn; Barbara Aguilar; Emily Tate; Christopher P Holmes; Randall A Scheuerman; Derek Maclean; May M Wu; Donald E Frail; Francisco J López; Richard Winneker; Brian J Arey; Ronald W Barrett
Allosteric activation of the follicle-stimulating hormone (FSH) receptor by selective, nonpeptide agonists.
The Journal of biological chemistry 2006;281(19):13226-33.
2006: Kaylon L Bruner-Tran; Zhiming Zhang; Esther Eisenberg; Richard Winneker; Kevin G Osteen
Down-regulation of endometrial matrix metalloproteinase-3 and -7 expression in vitro and therapeutic regression of experimental endometriosis in vivo by a novel nonsteroidal progesterone receptor agonist, tanaproget.
The Journal of clinical endocrinology and metabolism 2006;91(4):1554-60.
2006: M R Yudt; Tom Berrodin; Scott Jelinsky; L A Hanna; Eugene L Brown; Susan Chippari; Ramesh A Bhat; Richard Winneker; Zhiming Zhang
Selective and opposing actions of progesterone receptor isoforms in human endometrial stromal cells.
Molecular and cellular endocrinology 2006;247(1-2):116-26.
2006: Robert J Steffan; Edward Matelan; Mark A Ashwell; William J Moore; William R Solvibile; Eugene Trybulski; Christopher C Chadwick; Susan Chippari; Thomas Kenney; Richard Winneker; Amy Eckert; Lisa Borges-Marcucci; Steven J Adelman; Zhang Xu; Lidia Mosyak; Douglas C Harnish
Control of chronic inflammation with pathway selective estrogen receptor ligands.
Current topics in medicinal chemistry 2006;6(2):103-11.
2005: Jeffrey D Bray; Scott Jelinsky; Radhika Ghatge; Jenifer A Bray; Christopher Tunkey; Kathryn Saraf; Britta M Jacobsen; Jennifer K Richer; Eugene L Brown; Richard Winneker; Kathryn B Horwitz; C Richard Lyttle
Quantitative analysis of gene regulation by seven clinically relevant progestins suggests a highly similar mechanism of action through progesterone receptors in T47D breast cancer cells.
The Journal of steroid biochemistry and molecular biology 2005;97(4):328-41.
2005: Andrew Fensome; Reinhold Bender; Rajiv Chopra; Jeff Cohen; Mark A Collins; Valerie Hudak; Karl Malakian; Susan Lockhead; Andrea M Olland; Kristine Svenson; Eugene A Terefenko; Rayomand J Unwalla; James M Wilhelm; Scott Wolfrom; Yuan Zhu; Zhiming Zhang; Puwen Zhang; Richard Winneker; Jay Wrobel
Synthesis and structure-activity relationship of novel 6-aryl-1,4-dihydrobenzo[d][1,3]oxazine-2-thiones as progesterone receptor modulators leading to the potent and selective nonsteroidal progesterone receptor agonist tanaproget.
Journal of medicinal chemistry 2005;48(16):5092-5.
2005: Zhiming Zhang; Andrea M Olland; Yuan Zhu; Jeff Cohen; Tom Berrodin; Susan Chippari; Chandrasekaran Appavu; Shen Li; James Wilhem; Rajiv Chopra; Andrew Fensome; Puwen Zhang; Jay Wrobel; Rayomand J Unwalla; C Richard Lyttle; Richard Winneker
Molecular and pharmacological properties of a potent and selective novel nonsteroidal progesterone receptor agonist tanaproget.
The Journal of biological chemistry 2005;280(31):28468-75.
2005: Eugene A Terefenko; Jeffrey Kern; Andrew Fensome; Jay Wrobel; Yuan Zhu; Jeffrey Cohen; Richard Winneker; Zhiming Zhang; Puwen Zhang
SAR studies of 6-aryl-1,3-dihydrobenzimidazol-2-ones as progesterone receptor antagonists.
Bioorganic & medicinal chemistry letters 2005;15(15):3600-3.
2005: Rebecca A Shirk; Zhiming Zhang; Richard Winneker
Differential effects of estrogens and progestins on the anticoagulant tissue factor pathway inhibitor in the rat.
The Journal of steroid biochemistry and molecular biology 2005;94(4):361-8.
2005: Christopher C Chadwick; Susan Chippari; Edward Matelan; Lisa Borges-Marcucci; Amy M Eckert; James Carl Keith; Leo M Albert; Yelena Leathurby; Heather A Harris; Ramesh A Bhat; Mark A Ashwell; Eugene Trybulski; Richard Winneker; Steven J Adelman; Robert J Steffan; Douglas C Harnish
Identification of pathway-selective estrogen receptor ligands that inhibit NF-kappaB transcriptional activity.
Proceedings of the National Academy of Sciences of the United States of America 2005;102(7):2543-8.
2005: Richard Winneker; Andrew Fensome; Jay Wrobel; Zhiming Zhang; Puwen Zhang
Nonsteroidal progesterone receptor modulators: structure activity relationships.
Seminars in reproductive medicine 2005;23(1):46-57.
2004: Mark A Collins; Valerie Hudak; Reinhold Bender; Andrew Fensome; Puwen Zhang; Lori Miller; Richard Winneker; Zhiming Zhang; Yuan Zhu; Jeffrey Cohen; Rayomand J Unwalla; Jay Wrobel
Novel pyrrole-containing progesterone receptor modulators.
Bioorganic & medicinal chemistry letters 2004;14(9):2185-9.
2004: Dalei Shao; Tom Berrodin; Eric S Manas; Diane Hauze; Robert Powers; Ashok R Bapat; Daniel Gonder; Richard Winneker; Donald E Frail
Identification of novel estrogen receptor alpha antagonists.
The Journal of steroid biochemistry and molecular biology 2004;88(4-5):351-60.
2003: Jeffrey D Bray; Zhiming Zhang; Richard Winneker; C Richard Lyttle
Regulation of gene expression by PRA-910, a novel progesterone receptor modulator, in T47D cells.
Steroids 2003;68(10-13):995-1003.
2003: Richard Winneker; Daniel Bitran; Zhiming Zhang
The preclinical biology of a new potent and selective progestin: trimegestone.
Steroids 2003;68(10-13):915-20.
2003: Heather A Harris; Leo M Albert; Yelena Leathurby; Michael S Malamas; Richard E Mewshaw; Chris P Miller; Yogendra P Kharode; James Marzolf; Barry S Komm; Richard Winneker; Donald E Frail; Ruth A Henderson; Yuan Zhu; James Carl Keith
Evaluation of an estrogen receptor-beta agonist in animal models of human disease.
Endocrinology 2003;144(10):4241-9.
2003: Andrew Fensome; Marci Koko; Jay Wrobel; Puwen Zhang; Zhiming Zhang; Jeffrey Cohen; Scott G Lundeen; Kelly Rudnick; Yuan Zhu; Richard Winneker
Novel 5-aryl-1,3-dihydro-indole-2-thiones. potent, orally active progesterone receptor agonists.
Bioorganic & medicinal chemistry letters 2003;13(7):1317-20.
2003: Puwen Zhang; Eugene A Terefenko; Andrew Fensome; Jay Wrobel; Richard Winneker; Zhiming Zhang
Novel 6-aryl-1,4-dihydrobenzo[d]oxazine-2-thiones as potent, selective, and orally active nonsteroidal progesterone receptor agonists.
Bioorganic & medicinal chemistry letters 2003;13(7):1313-6.
2002: Andrew Fensome; Reinhold Bender; Jeffrey Cohen; Mark A Collins; Valerie A Mackner; Lori L Miller; John W Ullrich; Richard Winneker; Jay Wrobel; Puwen Zhang; Zhiming Zhang; Yuan Zhu
New progesterone receptor antagonists: 3,3-disubstituted-5-aryloxindoles.
Bioorganic & medicinal chemistry letters 2002;12(23):3487-90.
2002: Puwen Zhang; Eugene A Terefenko; Andrew Fensome; Jay Wrobel; Richard Winneker; Scott G Lundeen; Keith B Marschke; Zhiming Zhang
6-Aryl-1,4-dihydro-benzo[d][1,3]oxazin- 2-ones: a novel class of potent, selective, and orally active nonsteroidal progesterone receptor antagonists.
Journal of medicinal chemistry 2002;45(20):4379-82.
2002: Deepak Sampath; Richard Winneker; Zhiming Zhang
The angiogenic factor Cyr61 is induced by the progestin R5020 and is necessary for mammary adenocarcinoma cell growth.
Endocrine 2002;18(2):147-59.
2002: Puwen Zhang; Eugene A Terefenko; Andrew Fensome; Zhiming Zhang; Yuan Zhu; Jeffrey Cohen; Richard Winneker; Jay Wrobel; John Yardley
Potent nonsteroidal progesterone receptor agonists: synthesis and SAR study of 6-aryl benzoxazines.
Bioorganic & medicinal chemistry letters 2002;12(5):787-90.
2001: SG Lundeen; Z Zhang; Y Zhu; JM Carver; Richard Winneker
Rat uterine complement C3 expression as a model for progesterone receptor modulators: characterization of the new progestin trimegestone.
The Journal of steroid biochemistry and molecular biology 2001;78(2):137-43.
2001: Deepak Sampath; Richard Winneker; Zhiming Zhang
Cyr61, a member of the CCN family, is required for MCF-7 cell proliferation: regulation by 17beta-estradiol and overexpression in human breast cancer.
Endocrinology 2001;142(6):2540-8.
2001: Edward J Kilbourne; Richard Winneker
Serotonin 5-HT1 receptors potentiate histamine and thrombin stimulated prostaglandin synthesis in endothelial cells.
Thrombosis and haemostasis 2001;85(5):924-8.
2001: Deepak Sampath; Y Zhu; Richard Winneker; Zhiming Zhang
Aberrant expression of Cyr61, a member of the CCN (CTGF/Cyr61/Cef10/NOVH) family, and dysregulation by 17 beta-estradiol and basic fibroblast growth factor in human uterine leiomyomas.
The Journal of clinical endocrinology and metabolism 2001;86(4):1707-15.
2000: Z Zhang; SG Lundeen; Y Zhu; JM Carver; Richard Winneker
In vitro characterization of trimegestone: a new potent and selective progestin.
Steroids 2000;65(10-11):637-43.
1998: Istvan Merchenthaler; J M Funkhouser; JM Carver; SG Lundeen; K Ghosh; Richard Winneker
The effect of estrogens and antiestrogens in a rat model for hot flush.
Maturitas 1998;30(3):307-16.
1998: Christopher C Chadwick; L J Shaw; Richard Winneker
TNF-alpha and 9-cis-retinoic acid synergistically induce ICAM-1 expression: evidence for interaction of retinoid receptors with NF-kappa B.
Experimental cell research 1998;239(2):423-9.
1997: SG Lundeen; JM Carver; M L McKean; Richard Winneker
Characterization of the ovariectomized rat model for the evaluation of estrogen effects on plasma cholesterol levels.
Endocrinology 1997;138(4):1552-8.
1993: V Kumar; M R Bell; J R Wetzel; J L Herrmann; R McGarry; H P Schane; Richard Winneker; B W Snyder; A J Anzalone
Non-steroidal glucocorticoid-like substances: receptor binding and in vivo activity.
Journal of medicinal chemistry 1993;36(22):3278-85.
1992: John Mallamo; G M Pilling; J R Wetzel; P J Kowalczyk; M R Bell; R K Kullnig; F H Batzold; P E Juniewicz; Richard Winneker; H R Luss
Antiandrogenic steroidal sulfonyl heterocycles. Utility of electrostatic complementarity in defining bioisosteric sulfonyl heterocycles.
Journal of medicinal chemistry 1992;35(10):1663-70.
1990: R G Christiansen; M R Bell; T E D'Ambra; John Mallamo; J L Herrmann; J H Ackerman; C J Opalka; R K Kullnig; Richard Winneker; B W Snyder
Antiandrogenic steroidal sulfonylpyrazoles.
Journal of medicinal chemistry 1990;33(8):2094-100.
1990: B W Snyder; G D Beecham; Richard Winneker
Danazol suppression of luteinizing hormone in the rat: evidence for mediation by both androgen and estrogen receptors.
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.) 1990;194(1):54-7.
1990: P E Juniewicz; M McCarthy; B M Lemp; T A Barbolt; C Shaw; D M Hollenbaugh; Richard Winneker; Jerry Reel; F H Batzold
The effect of the steroidal androgen receptor antagonist, Win 49,596, on the prostate and testis of beagle dogs.
Endocrinology 1990;126(5):2625-34.
1990: Richard Winneker; M M Wagner; B Singh
A novel, nonsteroidal inhibitor of androgen binding to the rat androgen binding protein: diethyl [[[3-(2,6-dimethyl-4-pyridinyl)-4-fluorophenyl]amino]methylene] propanedioate.
Journal of medicinal chemistry 1990;33(1):129-32.
1989: Richard Winneker; M M Wagner; F H Batzold
Studies on the mechanism of action of Win 49596: a steroidal androgen receptor antagonist.
Journal of steroid biochemistry 1989;33(6):1133-8.
1989: B W Snyder; Richard Winneker; F H Batzold
Endocrine profile of Win 49596 in the rat: a novel androgen receptor antagonist.
Journal of steroid biochemistry 1989;33(6):1127-32.
1989: Richard Winneker; M M Wagner; C J Shaw; B W Snyder
Antiandrogens do not reverse androgen-induced inhibition of sex hormone-binding globulin levels in adult female rhesus monkeys.
Endocrinology 1989;125(2):715-20.
1989: B W Snyder; G D Beecham; Richard Winneker
Studies on the mechanism of action of danazol and gestrinone (R2323) in the rat: evidence for a masked estrogen component.
Fertility and sterility 1989;51(4):705-10.
1989: B W Snyder; Jerry Reel; Richard Winneker; F H Batzold; G O Potts
Effect of epostane, ZK 98299, and ZK 98734 on the interruption of pregnancy in the rat.
Biology of reproduction 1989;40(3):549-54.
1985: H P Schane; H R Harding; M R Bell; V D Castracane; Richard Winneker; B W Snyder
Glucocorticoid/antiinflammatory activities of nonsteroidal phenylpyrazoles in the rat.
Steroids 1985;45(2):171-85.
1984: Richard Winneker; M M Russell; C K Might; H P Schane
The interaction of nivazol with the glucocorticoid receptor from rat and rhesus monkey target tissues.
Steroids 1984;44(5):447-57.
1983: J H Clark; Richard Winneker; S C Guthrie; B M Markaverich
An endogenous ligand for the triphenylethylene antiestrogen binding site.
Endocrinology 1983;113(3):1167-9.
1983: Richard Winneker; J H Clark
Estrogenic stimulation of the antiestrogen specific binding site in rat uterus and liver.
Endocrinology 1983;112(6):1910-5.
1983: Richard Winneker; S C Guthrie; J H Clark
Characterization of a triphenylethylene-antiestrogen-binding site on rat serum low density lipoprotein.
Endocrinology 1983;112(5):1823-7.
1981: Richard Winneker; W V Welshons; J A Parsons
Estrogen receptor-like macromolecule in MtTW15 rat pituitary tumors: effects of antiestrogens.
Molecular and cellular endocrinology 1981;23(3):333-44.
1981: Richard Winneker; J A Parsons
Glucocorticoid-like actions of medroxyprogesterone acetate upon MtTW15 rat mammosomatotropic pituitary tumors.
Endocrinology 1981;109(1):99-105.
1981: Richard Winneker; J A Parsons
Effects of 17 beta-estradiol and medroxyprogesterone acetate upon MtTW15 mammosomatotropic pituitary tumor growth and hormone production in male and female rats.
Cancer research 1981;41(5):1772-7.
1977: Richard Winneker; M Tompkins; P Westenberger; J Harris
Morphological studies of chemically induced colon tumors in hamsters.
Experimental and molecular pathology 1977;27(1):19-34.